![](https://monteverdelaw.com/wp-content/uploads/case-logo/gemini-therapeutics-inc.jpg)
Gemini Therapeutics, Inc. (GMTX), relating to its proposed merger with Disc Medicine, Inc. Under the terms of the agreement, GMTX shareholders are expected to own 28% of the newly combined company.
Gemini Therapeutics, Inc. (GMTX), relating to its proposed merger with Disc Medicine, Inc. Under the terms of the agreement, GMTX shareholders are expected to own 28% of the newly combined company.